Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

UNCOVERED: 2 - The Untold Story

John Barnes reveals prostate cancer diagnosis as he speaks out on ‘taboo subject’ for men

Former Liverpool winger John Barnes has revealed he had his prostate removed following a cancer diagnosis, speaking out about what he calls a "taboo subject" for men. "Not many people know and it’s a bit of a taboo subject because we support women with breast cancer and it’s not even…

The Independent UK

More black men to be invited to prostate cancer screening trial

It comes as Health Secretary James Murray accepted a committee’s recommendation against a population-wide screening programme.

Evening Standard

Thousands more Black men to benefit from prostate cancer screening trial

Prostate cancer is more common, develops earlier and can be more aggressive in this group

The Independent UK

From analysis to the latest developments in health,
read the most diverse news in one place.

Jill Biden opens up on husband Joe’s cancer battle: ‘It’s been tough’

Former first lady Jill Biden has given an update on her husband’s cancer battle, saying that Joe Biden 's prostate cancer diagnosis has led to him getting "tired a little more often.” “Cancer takes its toll,” she told MSNOW . But she added that the former president is “still giving…

The Independent UK

Comedian Bobby Davro announces prostate cancer diagnosis despite experiencing no symptoms

Bobby Davro has announced his prostate cancer diagnosis, issuing a plea for others to undergo checks.

The Independent UK

Health Secretary accepts committee’s recommendation on prostate cancer screening

The move is a blow to campaigners, but the committee said screening all men using the prostate specific antigen test could do more harm than good.

Evening Standard

Bobby Davro issues warning after prostate cancer diagnosis

The comedian also suffered a stroke two years ago.

Evening Standard

Read news from The Economist, FT, and more,
with one subscription

Bobby Davro diagnosed with prostate cancer after symptom showed 'something wasn't right'

The former EastEnders star, 67, shared his ‘scary’ battle and the news that made him ‘cry with relief’

Evening Standard

Edap Tms Unveils FocalTherics Pivot, Targets 40% Growth on HIFU Expansion

Edap Tms (NASDAQ:EDAP) used its 2026 FocalTherics Investor Day to outline its shift toward becoming a “high-growth, pure-play robotic focal therapy company,” with management emphasizing the company’s Focal One robotic high-intensity focused ultrasound, or HIFU, platform for prostate cancer and futur

MarketBeat

Johnson & Johnson prostate cancer drug reduces risk of cancer spread and death in late-stage study

The study, which followed patients for over five ‌years, found that those ⁠who received ⁠the regimen were nine times more likely to have little to no detectable cancer in the prostate at the time of surgery compared with those given testosterone-blocking therapy alone.

The Economic Times

Novartis experimental actinium-based drug shows promise in prostate cancer treatment: Study

Novartis' new experimental actinium-based drug shows promise against prostate cancer. Early data on Sunday revealed anti-tumour activity, even in patients who previously received Novartis' Pluvicto. Response rates were higher in patients without prior Pluvicto treatment. Larger trials are planned to assess side effects. Novartis is increasing its focus on radioligand…

The Economic Times

Former Labour deputy leader Tom Watson announces cancer has returned

The Labour peer was initially diagnosed with non-aggressive prostate cancer in March 2023

The Independent UK

Why experts have advised against widespread prostate cancer screening

IN FULL

The Independent UK

Most UK men should not be offered prostate cancer screening, experts say

Government will consider committee’s guidance that says mass screening ‘likely to cause more harm than good’

The Guardian - UK

Get all your
news in one place.

100's of premium titles.
One news app.

The Independent UK

Majority of men in UK will not be offered routine prostate cancer screening

Black men have double the risk of prostate cancer

Evening Standard

Prostate cancer screening: Final guidance recommends against testing all men

Only men with a specific gene variant and a family history of certain cancers should be screened, experts have said.

The Independent UK

5 new podcasts to listen to this week

These are our top podcast picks.

International Business Times UK

Is Benjamin Netanyahu Dying? Online Rumors Explode After Israeli PM's Hospital Visit

The Israeli PM's latest hospital visit reignited questions about his health after recent prostate cancer treatment and past medical procedures.

Get all your
news in one place.

100's of premium titles.
One news app.

The Independent UK

Taxi driver tells passenger ‘you saved my life’ after advice led to cancer find

Brian Kelly’s conversation with a Prostate Cancer UK volunteer would prove to be life-changing.

MarketBeat

Candel Therapeutics Eyes Year-End BLA After Strong Prostate Cancer Data

Candel Therapeutics (NASDAQ:CADL) Chief Executive Officer Dr. Paul Peter Tak said the company remains focused on advancing its viral immunotherapy programs following newly presented prostate cancer data and as it prepares for a planned biologics license application submission by the end of the year.

Golf Monthly

How One Golfer Is Aiming To Set A New World Record Involving The Name 'Mark'

Mark Taylor is looking to raise £88,000 for Prostate Cancer UK by bringing 88 golfers called Mark together for a record breaking golf competition

The Independent UK

New blood test could show if prostate cancer treatment is failing

The discovery could lead to personalised treatments for the disease

The Guardian - UK

Prostate cancer screening can save lives but ‘absolute benefit is small’, study says

Although blood test reduces deaths by two for every 1,000 men screened, many could face unnecessary treatment

MarketBeat

MDxHealth Q1 Earnings Call Highlights

MDxHealth (NASDAQ:MDXH) reported first-quarter 2026 revenue of $27.4 million while announcing a strategic exit from its Resolve UTI testing business and the planned closure of its Plano, Texas, laboratory facility, a move executives said will sharpen the company’s focus on prostate cancer diagnostic

MarketBeat

Abeona Therapeutics Q1 Earnings Call Highlights

Abeona Therapeutics (NASDAQ:ABEO) reported early commercial momentum for ZEVASKYN in the first quarter of 2026, with executives highlighting new patient treatments, expanded treatment-center activation and a newly licensed prostate cancer cell therapy program during the company’s earnings call. Chi

1 2 3 4 5

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

University College London

the UK National Screening Committee

19 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.